We compared 5 isolated anti-Ro52 SS patients to 10 combined anti-Ro52 (comprising 2 anti-Ro52/Ro60 and 8 anti-Ro52/Ro60/La SS patients). Here, TRIM21 is linked to synovial sarcoma.